X4 Pharmaceuticals, Inc (XFOR) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 40 days, typically, give or take 21 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2025Wed, Nov 5, 2025before open 36 8-K
Q1 FY2025Thu, May 1, 2025before open 31 8-K
Q4 FY2024Tue, Mar 25, 2025before open 84 8-K
Q3 FY2024Wed, Nov 13, 2024before open 44 8-K
Q2 FY2024Thu, Aug 8, 2024before open 39 8-K
Q1 FY2024Tue, May 7, 2024before open 37 8-K
Q4 FY2023Thu, Mar 21, 2024before open 81 8-K
Q3 FY2023Thu, Nov 9, 2023before open 40 8-K

What they guided beta

Q3 FY2025 "An increase in the enrollment target for the pivotal Phase 3 4WARD study to 176 patients with enrollment now expected to be completed in third quarter of 2026." exhibit
Q3 FY2025 "With a strengthened cash runway to the end of 2028, X4 is now expected to be able to complete the 4WARD trial, file a potential sNDA for the chronic neutropenia indication, and, if successful, launch mavorixafor in this new indication by the end of 2028." exhibit
Q1 FY2025 "Document Exhibit 99.1 X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates 4WARD Phase 3 chronic neutropenia trial in full swing; full enrollment on track for 3Q or 4Q 2025 and top-line data in 2H 2026 Additional analyses of mavorixafor clinical trial data increase confidence in successful outcome of 4WARD trial XOLREMDI® net U.S. revenues $3.5 million since May 2024 launch Conference call and webcast today at 8:30 am ET BOSTON, Mass., May 1, 2025 – X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases " exhibit
Q1 FY2025 "X4 continues to expect full enrollment in the trial in the third or fourth quarter of 2025, and disclosure of top-line data in the second half of 2026." exhibit
Q1 FY2025 "The patent is expected to expire in the U.S. in March of 2041; similar patent applications are pending in Europe , China, Japan, and Canada ." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/XFOR
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/XFOR

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

XFOR earnings date badge

HTML

<a href="https://veritasdata.dev/company/XFOR/"><img src="https://veritasdata.dev/embed/XFOR.svg" alt="XFOR earnings date" width="240" height="56"></a>

Markdown

[![XFOR earnings date](https://veritasdata.dev/embed/XFOR.svg)](https://veritasdata.dev/company/XFOR/)

Script

<script async src="https://veritasdata.dev/embed/XFOR.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/XFOR"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.